https://www.selleckchem.com/pr....oducts/slf1081851-hy
003], and more patients with low handgrip strength [26 kg (men) and 18 (women); 67.8% vs. 55.5%, P 0.001], and slow gait speed [0.8 m/s (both ****es); 54.5% vs. 41.1%, P 0.001] than the HFrEF group, resulting in a similar sarcopenia prevalence in the two groups (18.1% vs. 21.6%, P = 0.191). Sarcopenia was an independent predictor of 1-year mortality in both HFpEF and HFrEF [hazard ratio (95% confidence interval) 2.42 (1.36-4.32), P = 0.003 in HFpEF and 2.02 (1.08-3.75), P = 0.027 in HFrEF; P for int